In the Spotlight
New Milestones publication now available
Every year, CCR makes remarkable contributions to the understanding, detection, treatment and prevention of cancer. This issue of our annual publication, Milestones, features 10 of our top scientific advances from the past year. These discoveries fall everywhere on the spectrum from basic science to clinical research, ranging from a change in our understanding of how cells replicate and divide to the first FDA-approved treatment for a rare cancer based on the results of an NCI trial. Our researchers have developed a novel drug delivery system inspired by bacterial spores, identified prognostic gene signatures for patients with different cancers and gathered data over 30 years to show that an immunotherapy essentially cures a rare precancerous disease.
Read MoreCelebrating CCR Careers: Jonathan R. Keller, Ph.D.
Jonathan R. Keller, Ph.D., an experimental hematologist who discovered interleukin-3 (IL-3) and explored the factors that give rise to leukemia, announces his retirement.
Read MoreCelebrating CCR Careers: Howard A. Young, Ph.D.
Howard A. Young, Ph.D., spent over 40 years researching cytokine gene expression, especially interferons and how they contribute to chronic inflammation and disease. Now, he has announced his retirement.
Read MoreCelebrating CCR Careers: William G. Stetler-Stevenson, M.D., Ph.D.
For over three decades, William G. Stetler-Stevenson, M.D., Ph.D., has been a leader in the field of tissue inhibitors of metalloproteinases (TIMP) biology and extracellular matrix regulation of cancer.
Read MoreCelebrating CCR Careers: Allan M. Weissman, M.D.
Allan M. Weissman, M.D., who explored the essential underpinning of ubiquitin in cancer, announces his retirement from the NCI.
Read MoreCelebrating CCR Careers: Kathleen Kelly, Ph.D.
Kathleen Kelly, Ph.D., who pioneered new frameworks for modeling and exploring how prostate cancer cells respond to anti-cancer drugs, announces her retirement from the NCI.
Read MoreCelebrating CCR Careers: Kenneth H. Kraemer, M.D.
For more than fifty years, Kenneth H. Kraemer, M.D., has investigated the molecular underpinnings and clinical manifestations of xeroderma pigmentosum, a rare disease that makes children highly vulnerable to skin damage and cancers from ultraviolet radiation, at the NCI.
Read MoreCCR Hosts “Frontiers in Basic Immunology” Symposium
CCR hosted a two-day international symposium, titled “Frontiers in Basic Immunology,” sponsored by the NCI Center of Excellence in Immunology (CEI). The program included a lineup of presentations from NCI and worldwide academic university speakers and a lively poster session.
Read MoreCCR Hosts Communications Course for Healthcare Providers in Oncology
Dedicated transdisciplinary teams of healthcare providers from the CCR’s Clinical Care Programs gathered to learn communication skills centered on essential topics of patient care.
Read MoreIn Memoriam: W. Michael Kuehl, M.D.
The CCR community is deeply saddened by the recent passing of W. Michael Kuehl, M.D., former Senior Investigator in the Genetics Branch.
Read More